NEULANDLAB 株式概要
ノイランド・ラボラトリーズ・リミテッドは、インド、欧州、米国、および国際的に医薬品原薬（API）を製造・販売している。 詳細
Neuland Laboratories Limited 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | ₹16,068.90 |
| 52週高値 | ₹16,560.75 |
| 52週安値 | ₹4,926.05 |
| ベータ | 0.98 |
| 11ヶ月の変化 | 15.18% |
| 3ヶ月変化 | 29.54% |
| 1年変化 | 210.71% |
| 33年間の変化 | 813.32% |
| 5年間の変化 | 3,519.94% |
| IPOからの変化 | 16,814.63% |
最新ニュース
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14
Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Recent updates
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Neuland Laboratories Limited's (NSE:NEULANDLAB) Shares Climb 44% But Its Business Is Yet to Catch Up
Aug 22Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?
Aug 02Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00
Jul 12Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking
Jul 02Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03株主還元
| NEULANDLAB | IN Pharmaceuticals | IN 市場 | |
|---|---|---|---|
| 7D | 7.9% | 1.1% | 2.0% |
| 1Y | 210.7% | 43.3% | 28.6% |
業界別リターン: NEULANDLAB過去 1 年間で43.3 % の収益を上げたIndian Pharmaceuticals業界を上回りました。
リターン対市場: NEULANDLAB過去 1 年間で28.6 % の収益を上げたIndian市場を上回りました。
価格変動
| NEULANDLAB volatility | |
|---|---|
| NEULANDLAB Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
安定した株価: NEULANDLABの株価は過去 3 か月間にわたって変動しています。
時間の経過による変動: NEULANDLABの weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1984 | 1,643 | Davuluri Rao | www.neulandlabs.com |
ノイランド・ラボラトリーズ・リミテッドは、インド、欧州、米国、および国際的に医薬品原薬（API）を製造・販売している。また、カスタム製造ソリューションやペプチド合成サービスも提供している。ノイランド・ラボラトリーズ・リミテッドは1984年に設立され、インドのハイデラバードに本社を置く。
Neuland Laboratories Limited 基礎のまとめ
| NEULANDLAB 基礎統計学 | |
|---|---|
| 時価総額 | ₹206.36b |
| 収益（TTM） | ₹2.80b |
| 売上高(TTM) | ₹15.28b |
73.8x
PER（株価収益率13.5x
P/SレシオNEULANDLAB は割高か？
公正価値と評価分析を参照収益と収入
| NEULANDLAB 損益計算書（TTM） | |
|---|---|
| 収益 | ₹15.28b |
| 売上原価 | ₹7.31b |
| 売上総利益 | ₹7.97b |
| その他の費用 | ₹5.17b |
| 収益 | ₹2.80b |
直近の収益報告
Sep 30, 2024
次回決算日
該当なし
| 一株当たり利益（EPS） | 217.98 |
| グロス・マージン | 52.14% |
| 純利益率 | 18.30% |
| 有利子負債／自己資本比率 | 6.7% |
NEULANDLAB の長期的なパフォーマンスは？
過去の実績と比較を見る